Affiliation:
1. Academician Ye.A. Vagner Perm State Medical University of Minzdrav of Russia
2. Perm Institute of Medical Workers Advanced Training
Abstract
The determination of the concentration of procalcitonin (PCT) in blood serum and other biological fluids is used for the diagnosis and monitoring of the course of sepsis and the syndrome of a systemic inflammatory reaction. This review summarizes the data on the diagnostic value of the definition of procalcitonin in the practice of urologists and andrologists. The content of procalcitonin in such biological fluids as urine, seminal plasma is almost 10 times higher than the level of this protein in blood serum: this phenomenon is manifested in physiological conditions and in pathological processes. The relationship of clinical and laboratory indicators of inflammation with the severity of urosepsis was analyzed. Elevated serum procalcitonin levels are considered as a predictor of septic shock in patients with urolithiasis, and determine the management tactics of patients with urinary tract obstruction. The marker function of this protein was studied in inflammation in the renal parenchyma, in malignant neoplasms of the kidneys, bladder, ureter, prostate and testis; in the diagnosis of testicular torsion and orchiepididymitis. The article describes the regular changes in the level of urinary procalcitonin depending on the severity of vesicoureteral reflux, the severity of the manifestations of the inflammatory reaction. There were significant differences in the concentration of procalcitonin in seminal plasma between the groups of men with reduced and normal ejaculate fertility.
Publisher
Institute of Cytology and Genetics, SB RAS
Reference53 articles.
1. Zvyagin A.A., Demidova V.S., Smirnov G.V. Dynamics of sepsis biomarkers as an indicator of the effectiveness of intensive care. Khirurgiya = Surgery. 2019; (2): 53-57. [In Russian]. doi: 10.17116/hirurgia201902153
2. Le Moullec J.M., Jullienne A., Chenais J., Lasmoles F., Guilana J.M., Mihaud G., Mukhtar M.S. The complete sequence of human preprocalcitonin. FEBS. 1984; 167: 93-97. doi: 10.1016/0014-5793(84)80839-x
3. Petrova O.V., Tarasov D.G., Nikulina D.M., Urtaeva Z.A., Motreva A.P., Mury-gina O.I., Levina N.N., Litvinova I.N., Kadykova A.V., Torishneva E.Yu. Value of pro-calcitonin in cardiosurgery practice. Klinicheskaya i eksperimental’naya khirurgiya = Clinical and Experimental Surgery. 2018; 6 (1): 51- 61. [In Russian].
4. Siriwardena A.K., Jegatheeswaran S., Mason J.M., Baltatzis M., Chan A., Sheen A.J., O’Reilly D., Jamdar S., Deshpande R., de Liguori Carino N., Satyadas T., Qamruddin A., Hayden K., Parker M.J., Butler J., Rajai A., McIntyre B. PROCalcitonin- based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial. Trials. 2019; 20 (1): 463. doi: 10.1186/s13063-019-3549-3
5. Shirali A.S., Wu J.X., Zhu C.Y., Ocampo A., Tseng C.H., Du L., Livhits M.J., Leung A.M., Yeh M.W. The role of serum procalcitonin in predicting bacterial sepsis in patients with hypothyroidism. J. Clin. Endocrinol. Metab. 2019; 104 (12): 5915-5922. doi: 10.1210/jc.2019-01082